LINDSAY FINCH: Open Payments
NPI 1346632346 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,937 in 66 payments from 16 companies in 2025. Trend: 2023 $1,744 · 2024 $1,307 · 2025 $1,937
Food & beverage: $1,937
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 6 | $406 |
| Abbott Laboratories | 4 | $301 |
| United Therapeutics Corporation | 9 | $210 |
| Alnylam Pharmaceuticals Inc. | 3 | $184 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $157 |
| BridgeBio Pharma, Inc. | 7 | $128 |
| Merck Sharp & Dohme LLC | 5 | $91 |
| Amgen Inc. | 5 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Tyvaso, LifeVest, AMVUTTRA, Attruby, Repatha, Kerendia, JARDIANCE.
Industry payments across NC — which companies pay providers there.
